grant
Project 05: Translational Therapeutics (TT)
Organization OHIO STATE UNIVERSITYLocation Columbus, UNITED STATESPosted 12 Sept 1997Deadline 31 Mar 2031
NIHUS FederalResearch GrantFY202621+ years oldAdolescent and Young AdultAdultAdult HumanAdvanced CancerAdvanced Malignant NeoplasmAntibodiesBiologic ModelsBiologicalBiological MarkersBiological ModelsBiotechBiotechnologyBody TissuesBreast CancerCCSGCancer BiologyCancer CauseCancer Center Support GrantCancer ControlCancer Control ScienceCancer EtiologyCancer PatientCancer SurvivorshipCancersCatchment AreaCell TherapyCenter for Cancer ResearchChemopreventionChildhood Solid NeoplasmChildhood Solid TumorChildren's HospitalClinicalClinical TrialsCollaborationsColorectal CancerCommunity OutreachComprehensive Cancer CenterDNA Molecular BiologyDecision MakingDevelopmentDiagnosisDirect CostsDisciplineDiseaseDisorderDoctor of PhilosophyDrugsEngineeringFemale Reproductive CancerFundingFutureGI cancersGI malignanciesGI tract cancersGastrointestinal CancerGastrointestinal Tract CancerGeneralized GrowthGenomicsGlioblastomaGoalsGrade IV Astrocytic NeoplasmGrade IV Astrocytic TumorGrade IV AstrocytomaGrowthGynecologic CancerGynecological CancerHematologic CancerHematologic MalignanciesHematologic NeoplasmsHematological MalignanciesHematological NeoplasmsHematological TumorHematopoietic CancerHost-Tumor InteractionImmune RegulatorsImmune mediated therapyImmune systemImmunogenomicsImmunologically Directed TherapyImmunomodulatorsImmunotherapeutic agentImmunotherapyIndividualInstitutionInterventionIntratumoral heterogeneityInvestigatorsJournalsMagazineMalignant Breast NeoplasmMalignant CellMalignant Female Reproductive System NeoplasmMalignant Gastrointestinal NeoplasmMalignant Gynecologic NeoplasmMalignant Gynecologic TumorMalignant Hematologic NeoplasmMalignant NeoplasmsMalignant Soft Tissue NeoplasmMalignant Thyroid Gland NeoplasmMalignant TumorMalignant Tumor of the Female Reproductive SystemMalignant Tumor of the LungMalignant Tumor of the ThyroidMalignant Tumor of the Thyroid GlandMalignant neoplasm of gastrointestinal tractMalignant neoplasm of lungMalignant neoplasm of thyroidMedicationMedicineModel SystemMolecularMolecular BiologyMolecular CarcinogenesisNCI Center for Cancer ResearchOhioOncogenicOncolytic virusesOnset of illnessOrganoidsOutcomePediatric HospitalsPediatric Solid TumorPeer ReviewPeer Review GrantsPh.D.PhDPharmaceutical AgentPharmaceutical PreparationsPharmaceuticalsPharmaciesPharmacologic SubstancePharmacological SubstancePharmacy facilityPopulationPreventative strategyPrevention strategyPreventive strategyPrognosisProliferatingPublicationsPublishingPulmonary CancerPulmonary malignant NeoplasmResearchResearch PersonnelResearch PriorityResearchersResistanceSarcomaScientific PublicationSignal PathwaySolid NeoplasmSolid TumorStrategic PlanningTherapeuticTherapeutic ResearchThyroid CancerTissue GrowthTissuesTranslatingUnderserved PopulationUniversitiesVeterinary MedicineWorkadulthoodbio-markersbiologicbiologic markerbiomarkercancer cellcancer preventioncancer progressioncell based interventioncell mediated interventioncell mediated therapiescell-based therapeuticcell-based therapycellular therapeuticcellular therapycollegecollegiatecommunity centercommunity centerscommunity engagementdevelopmentaldisease onsetdisorder onsetdrug developmentdrug/agentearly onsetengagement with communitiesgastrointestinal malignanciesglioblastoma multiformegynecologic malignancygynecological malignancyheterogeneity in tumorshost neoplasm interactionimmune drugsimmune modulatorsimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapeuticsimmune-based therapiesimmune-based treatmentsimmuno therapyimmunologic therapeuticsimmunomodulatory moleculesimmunoregulatorimmunoregulatory moleculesimmunotherapeuticsimmunotherapy agentimprovedinnovateinnovationinnovativeintra-tumoral heterogeneityintratumor heterogeneityinvestigator-initiated trialleukemialung cancerlung cancer early detectionlung cancer screeningmalignancymalignant breast tumormalignant soft tissue tumormeetingmeetingsmembermultidisciplinaryneo-antigen vaccineneoantigen vaccineneoplasm progressionneoplasm/cancerneoplastic progressionnew approachesnew drug treatmentsnew drugsnew pharmacological therapeuticnew technologynew therapeuticsnew therapynext generation therapeuticsnovelnovel approachesnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel strategiesnovel strategynovel technologiesnovel therapeuticsnovel therapyontogenypharmaceuticalpre-clinical studypreclinical studyprognosticprogramsrecruitresistantresponse to therapyresponse to treatmentsmall moleculespongioblastoma multiformetherapeutic agent developmenttherapeutic developmenttherapeutic responsetherapeutic targettherapy responsetranslational genomicstranslational therapeuticstranslational therapytreatment responsetreatment responsivenesstreatment trialtumortumor heterogeneitytumor progressionunder served areaunder served geographic areaunder served groupunder served individualunder served locationunder served peopleunder served populationunder served regionunderserved areaunderserved geographic areaunderserved groupunderserved individualunderserved locationunderserved peopleunderserved region
Description preview
PROJECT SUMMARY – TRANSLATIONAL THERAPEUTICS (TT)
The Translational Therapeutics (TT) Program at The Ohio State University Comprehensive Cancer Center (OSUCCC), co-led by David Carbone, MD, PhD, Blake Peterson, PhD, and Elaine Mardis, PhD, unites an outstanding team of 90 basic, translational and/or clinical researchers from 24 departments within…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click